Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in patients with multiple sclerosis and healthy controls and evaluated the influence of glatiramer acetate and vitamin D treatment on the microbiota....

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of investigative medicine Ročník 63; číslo 5; s. 729 - 734
Hlavní autoři:	Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Los Angeles, CA SAGE Publications 01.06.2015
Témata:	Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Adult Cholecalciferol - pharmacology Cholecalciferol - therapeutic use Dietary Supplements Female Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - physiology Glatiramer Acetate - pharmacology Glatiramer Acetate - therapeutic use Humans Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Middle Aged Multiple Sclerosis, Relapsing-Remitting - diagnosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Pilot Projects gut microbiome autoimmunity glatiramer acetate multiple sclerosis vitamin D
ISSN:	1081-5589, 1708-8267
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!